Clinical Trial Update: Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial update for Doxorubicin Transdrug in advanced hepatocellular carcinoma shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin Transdrug (Doxorubicin Transdrug)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2021-06-02